Total Payments
$4,688
2024 Payments
$17.19
Companies
18
Transactions
201
Medicare Patients
905
Medicare Billing
$136,089
Payment Breakdown by Category
Food & Beverage$2,887 (61.6%)
Travel$1,801 (38.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,887 | 198 | 61.6% |
| Travel and Lodging | $1,801 | 3 | 38.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $1,983 | 14 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,632 | 124 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $367.00 | 21 | $0 (2020) |
| GENZYME CORPORATION | $187.27 | 7 | $0 (2022) |
| Vapotherm Inc | $97.51 | 6 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $68.00 | 5 | $0 (2019) |
| Grifols USA, LLC | $60.22 | 4 | $0 (2019) |
| Insmed, Inc. | $58.11 | 4 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $42.98 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.21 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.19 | 1 | PFIZER INC. ($17.19) |
| 2023 | $1,859 | 6 | Genentech USA, Inc. ($1,859) |
| 2022 | $548.06 | 28 | GlaxoSmithKline, LLC. ($327.22) |
| 2021 | $308.17 | 19 | GlaxoSmithKline, LLC. ($294.11) |
| 2020 | $677.63 | 56 | GlaxoSmithKline, LLC. ($277.69) |
| 2019 | $944.33 | 59 | GlaxoSmithKline, LLC. ($504.38) |
| 2018 | $321.75 | 31 | GlaxoSmithKline, LLC. ($217.19) |
| 2017 | $10.96 | 1 | GlaxoSmithKline, LLC. ($10.96) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: VACCINES | ||||||
| 06/21/2023 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $138.62 | General |
| 06/21/2023 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $56.27 | General |
| 03/30/2023 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $1.34 | General |
| 03/29/2023 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $856.54 | General |
| 03/29/2023 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $805.58 | General |
| 03/29/2023 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $1.12 | General |
| 12/15/2022 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Airway Clearance Device | ||||||
| 12/02/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $119.50 | General |
| 10/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Immunology | ||||||
| 10/18/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $131.15 | General |
| Category: Immunology | ||||||
| 09/30/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: RESPIRATORY | ||||||
| 06/17/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 314 | 451 | $132,498 | $47,554 |
| 2021 | 5 | 323 | 453 | $135,695 | $51,574 |
| 2020 | 5 | 268 | 397 | $101,426 | $36,962 |
Total Patients
905
Total Services
1,301
Medicare Billing
$136,089
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 332 | $94,449 | $34,017 | 36.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 34 | $13,430 | $5,085 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,150 | $2,877 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 48 | $9,600 | $2,805 | 29.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,869 | $2,770 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 198 | 319 | $89,684 | $33,690 | 37.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 42 | $16,510 | $6,370 | 38.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $15,975 | $6,185 | 38.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,565 | $3,128 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 30 | $5,961 | $2,202 | 36.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 182 | 303 | $71,508 | $25,178 | 35.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 38 | 38 | $13,490 | $5,151 | 38.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 26 | $8,190 | $3,307 | 40.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $5,340 | $2,191 | 41.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 18 | $2,898 | $1,134 | 39.1% |
About Dr. Allen Salm, MD
Dr. Allen Salm, MD is a Pulmonary Disease healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710977392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allen Salm, MD has received a total of $4,688 in payments from pharmaceutical and medical device companies, with $17.19 received in 2024. These payments were reported across 201 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,887).
As a Medicare-enrolled provider, Salm has provided services to 905 Medicare beneficiaries, totaling 1,301 services with total Medicare billing of $136,089. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Marlton, NJ
- Active Since 10/25/2005
- Last Updated 01/30/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1710977392
Products in Payments
- TRELEGY ELLIPTA (Drug) $710.84
- NUCALA (Biological) $297.19
- ANORO (Drug) $258.57
- DUPIXENT (Biological) $230.25
- SYMBICORT (Drug) $210.26
- ANORO ELLIPTA (Drug) $178.23
- BREZTRI AEROSPHERE (Drug) $144.32
- Precision Flow (Device) $97.51
- Xolair (Biological) $90.88
- XOLAIR (Biological) $68.00
- BREO (Drug) $67.22
- Prolastin-C Liquid (Biological) $60.22
- Arikayce (Drug) $58.11
- (8874) inCourage (Device) $33.68
- Activase (Biological) $32.44
- OFEV (Drug) $28.28
- GLASSIA (Biological) $27.91
- LONHALA MAGNAIR (Drug) $20.03
- Hillrom - Life 2000 Ventilation System (Device) $19.64
- NIOX VERO (Device) $18.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Marlton
Dr. Mark Weir, Mb Chb, MB CHB
Pulmonary Disease — Payments: $7,553
Pulmonary Disease $7,553
Dr. Eric Sztejman, Md, MD
Pulmonary Disease — Payments: $4,910
Pulmonary Disease $4,910
Dr. Emilio Mazza, Md, MD
Pulmonary Disease — Payments: $4,892
Pulmonary Disease $4,892
Abhishek Agarwal, Md, MD
Pulmonary Disease — Payments: $4,388
Pulmonary Disease $4,388
Matthew Gordon, Md, MD
Pulmonary Disease — Payments: $4,385
Pulmonary Disease $4,385
Dr. Jonathan Galli, M.d, M.D
Pulmonary Disease — Payments: $3,450
Pulmonary Disease $3,450